Robert P. Lenk - 08 Nov 2023 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)

Role: Director
Signature: Andrew Sims, as attorney-in-fact
Issuer symbol: PSTV
Transactions as of: 08 Nov 2023
Net transactions value: +$14,926
Form type: 4
Filing time: 13 Nov 2023, 07:00:07 UTC
Previous filing: 08 Nov 2023
Next filing: 15 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PSTV	Common Stock	Purchase	$8,250	+5,000	+63%	$1.65	12,961	08 Nov 2023	Direct	F1
transaction	PSTV	Common Stock	Purchase	$6,676	+4,199	+32%	$1.59	17,160	09 Nov 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.70 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.59 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.70 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.59 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.